Compared to a slow pace, a brisk walking pace was associated with a lower risk of all-cause mortality in men (HR 0.79; 95% CI 0.69-0.90) and women (HR 0.73; 95% CI 0.62-0.85).
Cohort (n=318,185)
Does a brisk walking pace reduce the risk of all-cause and cause-specific mortality compared to a slow walking pace in adults aged 40 to 69 years?
A brisk walking pace is associated with a significantly lower risk of all-cause, cardiovascular, and respiratory mortality compared to a slow walking pace, independent of total walking time.
Hazard Ratio: 0.79 (95% CI 0.69–0.9)
PURPOSE: Walking pace is associated with all-cause and cardiovascular disease (CVD) mortality. Whether this association extends to other health outcomes and whether it is independent of total amount of time walked are currently unknown. Therefore, the aim of this study was to investigate whether usual walking pace is associated with a range of health outcomes. METHODS: UK Biobank participants (318,185 54% women) age 40 to 69 yr were included. Walking pace and total walking time were self-reported. The outcomes comprised: all-cause mortality as well as incidence and mortality from CVD, respiratory disease and cancer. The associations were investigated using Cox proportional hazard models. RESULTS: Over a mean of 5.0 yr ranging from 3.3 to 7.8, 5890 participants died, 18,568 developed CVD, 5430 respiratory disease and 19,234 cancer. In a fully adjusted model, compared to slow pace walkers, men and women, respectively, with a brisk pace having lower risk of mortality from all-causes (hazard ratio HR, 0.79; 95% confidence interval CI, 0.69-0.90 and HR, 0.73; 95% CI, 0.62-0.85), CVD (HR, 0.62; 95% CI, 0.50-0.76 and HR, 0.80; 95% CI, 0.73-0.88), respiratory disease (HR, 0.58; 95% CI, 0.43-0.78 and HR, 0.66; 95% CI, 0.57-0.77), chronic obstructive pulmonary disease (HR, 0.26; 95% CI, 0.12-0.56 and HR, 0.28; 95% CI, 0.16-0.49). No associations were found for all-cause cancer, colorectal, and breast cancer. However, brisk walking was associated with a higher risk of prostate cancer. CONCLUSIONS: Walking pace is associated with lower risk of a wide range of important health conditions, independently of overall time spent walking.
Celis‐Morales et al. (Wed,) conducted a cohort in General population (n=318,185). Brisk walking pace vs. Slow walking pace was evaluated on All-cause mortality (HR 0.79, 95% CI 0.69-0.90). Compared to a slow pace, a brisk walking pace was associated with a lower risk of all-cause mortality in men (HR 0.79; 95% CI 0.69-0.90) and women (HR 0.73; 95% CI 0.62-0.85).